Table 5.
Comparison of incidence of cardiovascular adverse events in the nonmedicated group (case, %).
| Group | N | Acute myocardial infarction | Heart failure | Cardiovascular death | Revascularization | Total occurrence |
|---|---|---|---|---|---|---|
| Administration group | 1848 | 46 | 21 | 10 | 17 | 5.09 (94) |
| Nonmedicated group | 273 | 11 | 8 | 3 | 4 | 9.52 (26) |
| Χ 2 | 8.774 | |||||
| P | 0.003 |